2022 Tutorial on Neoplastic Hematopathology: Cutaneous Lymphomas Including Mycosis Fungoides

The goal of this activity is to update physicians on the latest advances in neoplastic hematopathology to improve the diagnosis of harmful and even potentially deadly cancers that include Hodgkin lymphoma, non-Hodgkin lymphoma, plasma cell myeloma, acute and chronic leukemia, myeloproliferative neoplasms, myelodysplastic syndromes, histiocytic tumors, and related disorders. This activity will provide a forum to discuss recent advances in the classification of hematopoietic tumors, including clinical and morphologic features, as well as the application and interpretation of immunological and molecular techniques in the diagnosis and classification of these diseases.

Target Audience

This activity is designed for pathologists and other healthcare professionals dedicated to the diagnosis of hematological malignancies.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;
  • State how to utilize recent advances in the classification of hematopoietic tumors;
  • Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;
  • Describe how to implement the most recent classification of hematologic neoplasms;
  • Recall new discoveries that might impact future classifications of hematologic neoplasms;
  • Analyze the prognostic and therapeutic significance of new molecular genetic markers of these tumors.
Additional information
ACGME/ABMS Core Competencies: 
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Thelma Wright
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
Activity expires: 
Steven H. Swerdlow, MD
Professor of Pathology
University of Pittsburgh

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School Of Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
REGISTRATION: For additional information, click the button below or download the Convey MED app!
Please login or create an account to proceed.